220 related articles for article (PubMed ID: 29180837)
1. IL-33-ST2 Axis in Liver Disease: Progression and Challenge.
Sun Z; Chang B; Gao M; Zhang J; Zou Z
Mediators Inflamm; 2017; 2017():5314213. PubMed ID: 29180837
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
[TBL] [Abstract][Full Text] [Related]
3. IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis.
Gao Y; Liu Y; Yang M; Guo X; Zhang M; Li H; Li J; Zhao J
Oncotarget; 2016 Jun; 7(23):33649-61. PubMed ID: 27172901
[TBL] [Abstract][Full Text] [Related]
4. Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis.
Vasseur P; Dion S; Filliol A; Genet V; Lucas-Clerc C; Jean-Philippe G; Silvain C; Lecron JC; Piquet-Pellorce C; Samson M
Oncotarget; 2017 Jul; 8(30):48563-48574. PubMed ID: 28611297
[TBL] [Abstract][Full Text] [Related]
5. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
Chen WY; Li LC; Yang JL
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
[TBL] [Abstract][Full Text] [Related]
6. The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox.
Allegra A; Innao V; Tartarisco G; Pioggia G; Casciaro M; Musolino C; Gangemi S
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652497
[TBL] [Abstract][Full Text] [Related]
7. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
8. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
[TBL] [Abstract][Full Text] [Related]
9. IL-33/ST2 signaling in liver transplantation.
Tan Z; Sun B
Cell Mol Immunol; 2021 Mar; 18(3):761-763. PubMed ID: 33041341
[No Abstract] [Full Text] [Related]
10. IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system.
Franca RF; Costa RS; Silva JR; Peres RS; Mendonça LR; Colón DF; Alves-Filho JC; Cunha FQ
J Neuroinflammation; 2016 Jun; 13(1):159. PubMed ID: 27334012
[TBL] [Abstract][Full Text] [Related]
11. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice.
Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y
Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281
[TBL] [Abstract][Full Text] [Related]
12. The Role of IL-33/ST2 Pathway in Tumorigenesis.
Larsen KM; Minaya MK; Vaish V; Peña MMO
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205617
[TBL] [Abstract][Full Text] [Related]
13. Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding.
Jovicic N; Jeftic I; Jovanovic I; Radosavljevic G; Arsenijevic N; Lukic ML; Pejnovic N
PLoS One; 2015; 10(7):e0134089. PubMed ID: 26218873
[TBL] [Abstract][Full Text] [Related]
14. Effects of obesity on IL-33/ST2 system in heart, adipose tissue and liver: study in the experimental model of Zucker rats.
Ragusa R; Cabiati M; Guzzardi MA; D'Amico A; Giannessi D; Del Ry S; Caselli C
Exp Mol Pathol; 2017 Apr; 102(2):354-359. PubMed ID: 28274612
[TBL] [Abstract][Full Text] [Related]
15. IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.
Du LX; Wang YQ; Hua GQ; Mi WL
Neuroscience; 2018 Jan; 369():222-230. PubMed ID: 29175156
[TBL] [Abstract][Full Text] [Related]
16. Role of the IL-33-ST2 axis in sepsis.
Xu H; Turnquist HR; Hoffman R; Billiar TR
Mil Med Res; 2017; 4():3. PubMed ID: 28168040
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 33 is a guardian of barriers and a local alarmin.
Martin NT; Martin MU
Nat Immunol; 2016 Feb; 17(2):122-31. PubMed ID: 26784265
[TBL] [Abstract][Full Text] [Related]
18. [Research progress on the role of IL-33/ST2 axis in pathogenesis of allergic rhinitis].
Peng HS; Zhu XH
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 33(10):910-914. PubMed ID: 31623032
[No Abstract] [Full Text] [Related]
19. Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.
Abd Rachman Isnadi MF; Chin VK; Abd Majid R; Lee TY; Atmadini Abdullah M; Bello Omenesa R; Osamah Ibraheem Z; Basir R
Mediators Inflamm; 2018; 2018():5346413. PubMed ID: 29507527
[TBL] [Abstract][Full Text] [Related]
20. IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Popovic B; Golemac M; Podlech J; Zeleznjak J; Bilic-Zulle L; Lukic ML; Cicin-Sain L; Reddehase MJ; Sparwasser T; Krmpotic A; Jonjic S
PLoS Pathog; 2017 Apr; 13(4):e1006345. PubMed ID: 28448566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
